About Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer.
Iovance Biotherapeutics, Inc. (IOVA) Stock Score & Signals
Iovance Biotherapeutics, Inc. (IOVA) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 24 out of 100.
2BB score and signals
Iovance Biotherapeutics, Inc.’s current 2BB score is 24 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 66 | Strong |
| Quality | 100 | Very Strong |
| Risk | 42 | Moderate |
Company facts
| Headquarters | San Carlos, California, United States |
| Founded | 2007 |
| Employees | 975 |
| 52-week range | $1.68 – $5.63 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-22 | — | -0.103 | — | $128.42M |
| 2026-11-05 | — | -0.095 | — | $116.19M |
| 2026-08-06 | — | -0.1287 | — | $89.43M |
| 2026-05-06 | — | -0.14 | — | $85.76M |